Mind / Body Blog

Migraine medication induces blood-brain barrier dysfunction

Physiologic stress probably does the same, so it’s not clear whether this is a medication adverse effect. Either way, if true it’s bad news for brain integrity (protection from antigens, inflammatory cytokines etc.).

Migraine medication induces blood-brain barrier dysfunction

via OASIS.

 

Posted in Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged , , , , |

Expat Stress and Quality Mental Health Care – Family Matters Magazine Abu Dhabi – Budapest – Warsaw – Shanghai

I discovered edited versions of a popular article of mine on quality-centered (rather than upfront cost-savings centered) psychiatric diagnosis and treatment syndicated in several publications by the British International School. I guess it somehow leaked out of China. Either way, have a look. The issuu layout is stunning. Comments welcome.

http://issuu.com/britishinternationalschool/docs/abu-dhabi-family-matters-issue-1/65

http://issuu.com/britishinternationalschool/docs/budapest-family-matters-issue-1/73

http://issuu.com/Britishinternationalschool/docs/familymatterswarsaw/61

http://issuu.com/Britishinternationalschool/docs/familymatters7/77

The original expat mental health piece was published in the Global Health Care Shanghai newsletter. Another version authorized by me and focusing on corporate mental health was printed in Human Resource Executive.
A piece on mental health care in China in general (Quality psychiatric care is needed. Op-Ed. China Daily, July 5, 2010) was published in China Daily.

 

 

 

Posted in China, Fifth Avenue Concierge Medicine, Health, keto, News, Psychiatry/Neurology | Tagged |

The Tale of the Telomeres Gets Ever-More Complex

Another nicely written article by  Joan Arehart-Treichel, on a supercool topic.

PsychiatryOnline | Psychiatric News | News Article.

Psychiatric News   |  

Volume 47 Number 17 page 18-18
American Psychiatric Association

Clinical and Research News

The Tale of the Telomeres Gets Ever-More Complex
Joan Arehart-Treichel

Telomere length is a marker of aging, and mental health seems to have an influence on it. But whether interventions to stave off telomere shortening could also delay aging remains to be seen.

Your destiny may be written, not in the stars, but in the telomeres that cap the ends of your chromosomes.

And your telomeres’ fate in turn may be influenced by your mental health.

This fascinating saga is becoming even more intriguing as it plays out.

telomere.png

This illustration depicts two chromosomes. The red tips on the ends of the chromosomes represent telomeres.

Knorre/Shutterstock

In 1965, scientists reported that the older a person is, the fewer times his or her cells divide when cultured in the lab. In 1990, they reported that each time a human cell divides in the lab culture, the telomeres shorten a bit, until they get so short that the cell is unable to divide further and dies.

In 2006, Naomi Simon, M.D., an associate professor of psychiatry at Harvard Medical School, and colleagues found that individuals with mood disorders have shorter telomeres than do healthy control subjects (Psychiatric News, June 2, 2006). Last year, scientists found that children who had been institutionalized had shorter telomeres than children who had not (Psychiatric News, July 1, 2011) and that hostility can chip away at people’s telomere length (Psychiatric News, December 16, 2011).

And now Lawrence Honig, M.D., Ph.D., a professor of clinical neurology at Columbia University, and his colleagues have found that telomere length may predict death in older people. The results appeared online July 28 in the Archives of Neurology.

The cohort that Honig and his team studied included 1,978 individuals who ranged in age from 66 to 101, with an average age of 78. The sample was also multiethnic—mostly African American, Hispanic, and non-Hispanic white.

The scientists drew blood from the subjects during a baseline visit, extracted white-cell DNA, and then determined the length of the telomeres within the DNA. The scientists followed the subjects for an average of eight years. They then assessed whether telomere length predicted mortality, taking age, gender, ethnicity, education, APOEe4 carrier status, and dementia into consideration.

They found that telomere length predicted remaining lifespan. That is, telomeres were significantly shorter in those who subsequently died in the follow-up period than in those who survived.

Why this is the case isn’t clear, they acknowledged. It could be that truncated telomeres lead to disease and death. “Evidence from cell culture and from animal models suggests that very short telomeres are themselves deleterious, increasing errors in the cell division process and possibly the development of cancer,” they noted. Or it could be that some environmental or genetic influences are both shortening telomeres and causing death.

Gender Differences Discovered

The scientists also made two other key findings. One was that telomeres were significantly shorter in male subjects than in female ones. The other one was that while telomeres were generally shorter in subjects who were older, there were wide variations in telomere length among people of a comparable chronological age. “Indeed, the variation between individuals within age groups is larger than the effect of many years of aging,” they said. And the reasons for such variation appear to lie in findings obtained by other researchers.

Specifically, evidence suggests that telomere length is a heritable characteristic, with varying estimates of heritability as high as 80 percent. But that leaves some 20 percent of the length to be determined by the environment, and both negative and positive environmental factors seem to have an impact on it.

The negative factors are things such as childhood adversity, mood disorders, and hostility. The positive factors are things such as a good diet and exercise. Telomeres even appear capable of growing longer, depending on the individual and the environment.

Clinical Implications Cited

The new findings have implications for various clinicians, including psychiatrists, but the “implications depend upon whether telomeres are a marker of biological aging or a causative factor in the pathway of biological aging,” Honig told Psychiatric News. “If the former, then it is possible that telomere length might help us monitor the aging process. If the latter, then intervening in the telomere maintenance pathway might help alleviate some of the features of aging.”

He and his colleagues will now be looking at “what changes there are in telomere length longitudinally,” Honig said. “And we are very actively looking for genes that might influence telomere length….”

These data “continue to support the hypothesis that telomere length is a marker of aging,” Simon told Psychiatric News. “As the authors note, however, there was more variability in telomere length among individuals within the same age cohort than change in telomere length over time, suggesting that much of telomere length is determined by other factors such as genetics, and, as they found, gender.”

“More research,” she continued, “is needed to understand the underlying biology of the telomere length–aging relationship, what factors may influence changes in telomere length over time, and whether interventions to reduce the rate of telomere length shortening in individuals would have health benefits or not, as telomere biology is complex and intricately involved in cancer development as well.”

The study was funded by the National Institutes of Health, the Alzheimer’s Association, the Henry P. Panasci Fund, and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain.

Posted in Aging, epigenetics, Health, keto | Tagged , , , , , |

The Neuropsychiatry of Headache – Academic and Professional Books – Cambridge University Press

Large jacket version

Cambridge University Press

The Neuropsychiatry of Headache

Edited by: Mark W. Green, Department of Neurology, Mount Sinai School of Medicine, New York

Edited by: Philip R. Muskin, Department of Psychiatry, Columbia University Presbyterian Hospital, New York

View All Contributors

Kathleen Mullin, Dawn C. Buse, C. Mark Sollars, Richard B. Lipton, Mark W. Green, Robert G. Kaniecki, Mallika Lavakumar, Philip R. Muskin, Peter A. Shapiro, Justin M. Nash, Rabin Chandran, Lucy Rathier, Carolyn B. Britton, Margaret E. M. Haglund, Eric D. Collins, Sander Markx, Rob Cowan, Nomita Sonty, Elizabeth Haase, Maurice Preter, Samuel Lieblich, Filza Hussain

Hardback

ISBN:9781107026209

17 b/w illus. 6 colour illus. 22 tables

Dimensions: 246 x 189 mm

$80.00 (C)

Whilst the vast majority of headaches are minor ailments, some patients develop chronic symptoms that have psychiatric dimensions. These symptoms can be immensely challenging to manage and can have a serious impact on the patient’s quality of life. The relationship between headache and psychiatric disease is often rationalized as cause and effect; however, the interplay between the two is complex. Management of each of the co-morbid disorders affects the other one in positive and/or negative ways. The Neuropsychiatry of Headache details the current concepts of various headache conditions and the psychiatric syndromes; topics covered include migraine, mood disorders, medication overuse and personality disorders. Headache specialists, neurologists, psychiatrists, neuropsychiatrists and neuropsychologists will find this an invaluable resource for understanding and co-managing these conditions.

Table of contents

• Includes current concepts of headache diagnosis and management

• Examines psychiatric co-morbidities of various types of headache and how to co-manage them

• The only book of its kind

via The Neuropsychiatry of Headache – Academic and Professional Books – Cambridge University Press.

http://www.amazon.com/The-Neuropsychiatry-Headache-Mark-Green/dp/1107026202/ref=sr_1_1?ie=UTF8&qid=1376652926&sr=8-1&keywords=green+muskin

 

Posted in Affective Neuroscience, dietary, epigenetics, Events, Forensic Neuropsychiatry, Health, keto, News, Psychiatry/Neurology | Tagged , , , , , , , , , |

Chocolate consumption and risk of stroke

Articles

Chocolate consumption and risk of stroke

A prospective cohort of men and meta-analysis

Susanna C. Larsson, PhD,

Jarmo Virtamo, MD and

Alicja Wolk, DMSc

+ Author Affiliations

From the Division of Nutritional Epidemiology (S.C.L., A.W.), Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; and Department of Chronic Disease Prevention (J.V.), National Institute for Health and Welfare, Helsinki, Finland.

Correspondence & reprint requests to Dr. Larsson: susanna.larsson@ki.se

View Complete Disclosures

Abstract

Objective: To investigate the association between chocolate consumption and risk of stroke in men and conduct a meta-analysis to summarize available evidence from prospective studies of chocolate consumption and stroke.

Methods: We prospectively followed 37,103 men in the Cohort of Swedish Men. Chocolate consumption was assessed at baseline using a food-frequency questionnaire. Cases of first stroke were ascertained from the Swedish Hospital Discharge Registry. For the meta-analysis, pertinent studies were identified by searching the PubMed and EMBASE databases through January 13, 2012. Study-specific results were combined using a random-effects model.

Results: During 10.2 years of follow-up, we ascertained 1,995 incident stroke cases, including 1,511 cerebral infarctions, 321 hemorrhagic strokes, and 163 unspecified strokes. High chocolate consumption was associated with a lower risk of stroke. The multivariable relative risk of stroke comparing the highest quartile of chocolate consumption (median 62.9 g/week) with the lowest quartile (median 0 g/week) was 0.83 (95 % CI 0.70–0.99). The association did not differ by stroke subtypes. In a meta-analysis of 5 studies, with a total of 4,260 stroke cases, the overall relative risk of stroke for the highest vs lowest category of chocolate consumption was 0.81 (95% CI 0.73–0.90), without heterogeneity among studies (p = 0.47).

Conclusion: These findings suggest that moderate chocolate consumption may lower the risk of stroke.

Footnotes

Study funding: Supported by research grants from the Swedish Council for Working Life and Social Research (FAS) and the Swedish Research Council/Committee for Infrastructure and by a Research Fellow grant from Karolinska Institutet (to Dr. Larsson). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the article.

Received February 2, 2012.

Accepted May 1, 2012.

Copyright © 2012 by AAN Enterprises, Inc.

Responses to this article

Matthew R Walters

Acute effect of chocolate ingestion on the cerebral vasculature Neurology published online September 5, 2012

Full Text

via Chocolate consumption and risk of stroke.

Posted in Health, keto, metabolic, new treatments | Tagged , , |